A study in The Journal of Experimental Medicine says that a novel immune-boosting drug combination eradicates brain cancer in mice. Glioblastoma is the most aggressive form of brain cancer, and current treatments only modestly prolong patient survival. Immune cells called T cells have the capacity to attack and kill tumor cells, but tumors can counteract this attack by creating an environment that dampens T cell activity. T cells have ways of limiting their own ...
Read More
No comments:
Post a Comment